<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-72698</identifier>
<setSpec>0300-8932</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Prognosis and management of patients with acute coronary syndrome and polyvascular disease</dc:title>
<dc:description xml:lang="en">Introduction and objectives. To assess prognosis and patterns of care in patients with acute coronary syndrome and peripheral arterial disease (PAD), cerebrovascular disease or both (ie, polyvascular disease) in everyday clinical practice. Methods. We used data from the MASCARA acute coronary syndrome registry for 2004 and 2005. Patients were stratified according to the presence of PAD, cerebrovascular disease, neither, or both. In-hospital management, treatment at discharge and outcomes at 6 months were recorded. Results. Of 6745 patients, 597 (8.85%) had PAD, 392 (5.8%) had cerebrovascular disease, 131 (1.94%) had both, and 5625 (83.4%) had neither. Patients with polyvascular disease had more extensive coronary disease, but less often received regularly recommended treatment (ie, 75% with PAD received aspirin at discharge versus 84% of those without). In-hospital and 6-month mortality were significantly higher (P &lt; .001) in patients with PAD (9.1% and 24.5%, respectively) or cerebrovascular disease (9.2% and 22.4%, respectively) or, especially, both (16.0% and 29.8%, respectively) than in those free from these conditions (4.8% and 10.8%, respectively). Cerebrovascular disease, PAD and their combination were all independently associated with in-hospital and 6-month mortality: for cerebrovascular disease, the odds ratio (OR) for mortality at 6 months was 1.45 (95% confidence interval [CI], 1.10&#150;2.02); for PAD, it was 1.88 (95% CI, 1.45&#150;2.40); and for both combined, 1.88 (95% CI, 1.17&#150;3.00). Conclusions. Patients with acute coronary syndrome and concomitant arterial disease had more extensive coronary artery disease and poorer outcomes, both inhospital and at 6 months, but frequently did not receive regularly recommended treatment (AU)</dc:description>
<dc:creator>Civeira, Emilia</dc:creator>
<dc:creator>Marsal, Josep R</dc:creator>
<dc:creator>Cascant, Purificación</dc:creator>
<dc:creator>Ferreira-González, Ignacio</dc:creator>
<dc:creator>Arós, Fernando</dc:creator>
<dc:creator>Sánchez, Pedro L</dc:creator>
<dc:creator>Heras, Magda</dc:creator>
<dc:creator>Permanyer Miralda, Gaietá</dc:creator>
<dc:creator>Cuñat, José</dc:creator>
<dc:creator>Marrugat, Jaume</dc:creator>
<dc:creator>Ribera, Aída</dc:creator>
<dc:creator>Bueno, Héctor</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción y objetivos. Valorar el pronóstico y los patrones de manejo de pacientes con síndrome coronario agudo y arteriopatía periférica, enfermedad cerebrovascular o ambos (enfermedad polivascular) en condiciones de práctica clínica real. Métodos. Se utilizaron los datos del registro MASCARA de síndrome coronario agudo entre 2004 y 2005. Se estratificó a los pacientes según presentaran arteriopatía periférica, enfermedad cerebrovascular, ambas o ninguna. Se analizaron el manejo intrahospitalario, el tratamiento al alta y los resultados clínicos a 6 meses. Resultados. De 6.745 pacientes, 597 (8,85%) tenían arteriopatía periférica; 392 (5,8%), enfermedad cerebrovascular; 131 (1,94%), ambas y 5.625 (83,4%), ninguna. Los pacientes con enfermedad polivascular tenían enfermedad coronaria más extensa, pero recibieron menos tratamientos habitualmente recomendados (por ejemplo, recibieron aspirina al alta el 75% de los pacientes con arteriopatía periférica y el 84% de los libres de ella). La mortalidad hospitalaria y a 6 meses fue más alta en pacientes con arteriopatía periférica (el 9,1 y el 24,5%, respectivamente), enfermedad cerebrovascular (el 9,2 y el 22,4%) y especialmente con ambas (el 16 y el 29,8%) que en los libres de estas afecciones (el 4,8 y el 10,8%) (p &lt; 0,001). Tanto la arteriopatía periférica y la enfermedad cerebrovascular como su combinación se asociaron independientemente a la mortalidad intrahospitalaria y a los 6 meses: odds ratio (intervalo de confianza del 95%) a 6 meses, 1,45 (1,1-2,02) en enfermedad cerebrovascular, 1,88 (1,45-2,4) en arteriopatía periférica y 1,88 (1,17-3) en la combinación de ambas. Conclusiones. Los pacientes con síndrome coronario agudo y arteriopatía concomitante tienen enfermedad coronaria más extensa y peores resultados clínicos intrahospitalarios y a los 6 meses, pero habitualmente reciben menos tratamientos regularmente recomendados (AU)</dc:description>
<dc:source>Rev Esp Cardiol;62(9): 1012-1021, sept. 2009. tab, ilus</dc:source>
<dc:identifier>ibc-72698</dc:identifier>
<dc:title xml:lang="es">Pronóstico y manejo de los pacientes con síndrome coronario agudo y enfermedad polivascular</dc:title>
<dc:subject>^d8250^s22002</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d7152^s22012</dc:subject>
<dc:subject>^d2834^s22002</dc:subject>
<dc:subject>^d2359^s22012</dc:subject>
<dc:subject>^d2359^s22067</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d24772</dc:subject>
<dc:subject>^d2359^s22016</dc:subject>
<dc:subject>^d28596</dc:subject>
<dc:subject>^d8249^s22002</dc:subject>
<dc:subject>^d24811</dc:subject>
<dc:subject>^d34247^s22054</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d34247^s22012</dc:subject>
<dc:type>article</dc:type>
<dc:date>200909</dc:date>
</metadata>
</record>
</ibecs-document>
